Participated · Series B · Nov 2021

aptihealth is a health tech behavioral health provider. The company delivers behavioral health services supported by clinical science, technology, and services to connect patients, providers, community organizations, and health plans. aptihealth has closed a $50 million Series B funding round. Investors in the round included Takeda Digital Ventures, Pivotal Life Sciences, Vista Credit Partners, Olive Tree Ventures, Claritas Capital, and What If Ventures. The company plans to use the fresh capital to expand investment in clinical science, technology, and services to make it easy, effective, and efficient for stakeholders to work together securely.

Led · Equity · Sep 2021

Renewvia Energy develops, installs, owns and operates commercial and community solar power systems and mini-grid utilities across three continents. The company offers end-to-end services including turnkey solar installation, integrated financing, and solar consulting. Renewvia positions itself as a leading mini-grid utility and commercial solar developer in Sub-Saharan Africa while also serving a growing U.S. commercial customer base. Its existing portfolio and project pipeline of mini-grids is projected to serve over 350,000 individuals and small businesses in remote off-grid areas, offsetting 2,800 tons of carbon and creating hundreds of construction and full-time jobs by 2024. Renewvia intends to accelerate growth in the U.S. and Africa to meet increasing demand for distributed commercial solar services. The company recently received a capital commitment to support corporate growth and geographic expansion.

Led · Seed · Sep 2021

Naborforce is a Richmond, VA-based elder tech company that connects older adults to a network of "Nabors" for on-demand support and social engagement. Its technology platform leverages community to dispatch a vetted network of local Nabors, on-demand and ready, to support aging in place and provide opportunities for older adults to remain social and active. Led by Paige Wilson, CEO and founder, the company operates in Richmond, Charlottesville, Williamsburg, and Virginia Beach in Virginia, plus Bethesda, MD, and Atlanta, GA. On August 15, 2022, FinSMEs reported Naborforce closed a $9M Series A financing. The round was led by Translink Capital. The company intends to use the funds to further invest in its technology-driven solution and to build the team to lead its expansion across the county. Naborforce provides a technology platform that links aging adults with a network of care providers aimed at combating isolation and other social determinants of health. The company is led by CEO and founder Paige Wilson and operates as a tech-enabled companion and care-connection service. It currently serves Richmond and Charlottesville in Virginia, and Raleigh, Wake County, Chapel Hill and Durham in North Carolina. Naborforce plans to expand its geographic reach and operations using newly raised capital. The company will roll out to 10 additional markets over the next year and will begin announcing new locations in September. The funding is intended to support that market expansion and operational growth.

Participated · Series B · Jul 2021

Swift Medical builds AI-driven digital wound care tools and an imaging app used to standardize assessment, documentation, and remote care across the continuum of care. Core product offerings highlighted in the announcement include SmartTissue™, AutoDepth™ and HealingIndex™, which aim to improve wound evaluations, reduce treatment variability and identify risk more accurately. The company reports being the trusted wound care technology partner of more than 4,000 healthcare facilities in North America with over 20,000 clinical users. Its platform has captured more than 20 million wound images and 40 million assessments, which underpin its clinical analytics and remote-care capabilities. Swift says its technology is associated with 37% faster wound healing and a 39% increase in measurement accuracy on darker skin tones in cited studies. Headquartered in Toronto, Swift operates across the U.S. and Canada and is pursuing broader commercialization and deployment of its AI tools. Swift Medical provides an AI-driven digital wound care platform that offers high-precision imaging, compliant documentation, clinical analytics, and remote care. The company serves more than 4,000 healthcare facilities across North America and has over 20,000 clinical users. Its platform has captured more than 20 million wound images and 40 million assessments, supporting standardized and equitable wound care. Headquartered in Toronto, Swift is expanding operations across the U.S. and Canada. The company plans significant platform enhancements in 2024, including enhanced data security, improved interoperability, and enhanced device capabilities. The recent financing is intended to accelerate those technology improvements and expand the company’s reach. Swift Medical offers an AI-powered digital wound care platform that lets patients and clinicians capture high-precision wound images with a mobile phone, autonomously determine wound dimensions and clinical characteristics, enable virtual wound consultations, and provide real-time predictive insights. The technology is used by over 4,000 healthcare organizations across all 50 states and spans the full continuum of care. The company says it has grown 300% year-over-year in every new market it has entered over the past three years. Swift Medical positions itself as the dominant market player in digital wound management and emphasizes improving prevention, treatment, and management of wounds. With the new funding, the company plans to expand its market position and scale its platform across the care continuum in North America and continue growing its team. The stated mission is to prevent wounds before they occur and improve quality of care for every patient with a wound. Swift Medical offers an enterprise-grade, smartphone-ready Swift Skin and Wound software that delivers advanced wound visualization and touchless 3D measurement without touching the wound or requiring extra equipment. The platform captures images and measurements including wound depth, provides automatic risk scoring, schedules assessments, and supports claims submission to streamline clinical and administrative wound care workflows. Swift has been adopted by over 1,000 healthcare facilities managing more than 100,000 beds and reports helping heal over 10,000 patients a month. The company has partnerships with PointClickCare and Healogics and positions itself as a global market leader and enterprise solutions partner in digital wound care management. Management says the Series A funding will be used to expand reach and bring Swift’s solution to every bedside in hospitals and care facilities. Swift frames its mission around digitizing wound care management to augment clinician capabilities and address the global burden of chronic wounds.

Participated · Series B · Jul 2020

Kindbody operates a network of ownership-operated and partner fertility clinics and a technology platform that delivers employer-sponsored family-building benefits across the full reproductive spectrum from preconception through menopause. The company integrates virtual and in-person care and manages services including fertility assessment, preservation, genetic testing, IVF, donor and surrogacy services, adoption support, and mental and emotional care. Kindbody says its direct-provider model saves employers 25%–30% by contracting to deliver comprehensive care, improving cost, experience, and outcomes. It serves 112 large employers covering more than 2.4 million lives and treats patients at 32 signature clinics plus hundreds of partner clinics. Leadership has signaled plans to use strategic investments to expand into geographies with the greatest demand for high-quality fertility care. Kindbody operates a technology-driven network of fertility clinics and provides employer-contracted family-building benefits, delivering both virtual and in-person care. Led by founder and chairwoman Gina Bartasi, the company owns and operates 31 clinics nationwide and contracts directly with employers. In 2022 the company made three strategic acquisitions—including Vios Fertility Institute, a genomics company adding genetic testing and carrier screening, and a gestational surrogacy agency—to expand its end-to-end care model. Kindbody plans to open ten new clinics in 2023 in underserved U.S. markets with the greatest demand for affordable, high-quality fertility healthcare. The company raised $100M in the latest funding round, bringing its valuation to $1.8 billion and total equity and debt funding to more than $290M. It intends to use the proceeds to add new clinics in underserved U.S. markets and to invest in operations to further enhance its care model. Kindbody is a New York City–based fertility and family-building company founded in 2018 that provides fertility, gynecology and family-building services. It operates over 300 locations, including signature and partner clinics as well as mobile clinics. The company’s suite covers egg freezing, IVF, IUI, egg and sperm donation, adoption and surrogacy, maternity care, ongoing gynecology and holistic wellness, plus local and virtual events supporting community education and LGBTQ+ inclusivity. Kindbody also offers a fertility benefit solution to employers. Its proprietary patient portal and electronic medical record platform enable machine-learning to reduce variable decision making among providers and improve outcomes. In June 2021 the company raised $62M in a Series C to accelerate growth, enhance its proprietary technology, and expand access to partner, signature, and mobile clinics. The company is led by CEO Gina Bartasi and a senior leadership team including Annbeth Eschbach, Dr. Lynn Westphal, Meredith Whitney, Cindy Gentry, Shilpa Patel, Dr. Fahimeh Sasan and Richard Forsythe. Kindbody provides end-to-end fertility, gynecology, and family-building care, serving patients from preconception through postpartum. Its services include fertility treatments such as IVF and egg freezing, gynecology, wellness, and LGBTQ+ services. The company operates as both a provider and a network solution, working with employers as a full-service benefits solution and directly with patients. Kindbody leverages proprietary technology to deliver a seamless member experience and data-driven results across its 180+ Kindbody and Center of Excellence (COE) locations. The clinical leadership includes CMO Dr. Lynn Westphal and Founding Ob/Gyn Dr. Fahimeh Sasan, and the company is led by Founder and CEO Gina Bartasi. Following the Series B, Kindbody plans to expand its national footprint and build an international presence through brick-and-mortar locations and a COE network of partner clinics. Kindbody operates pop-up and brick‑and‑mortar fertility clinics and a mobile van that provides free AMH blood tests and directs patients to fuller assessments and services. Its core paid service is egg freezing, priced at $6,000 per cycle (excluding medication costs), below market averages; it also offers IVF and IUI services priced in line with competitors. The company leverages millennial‑focused branding and social media to drive attendance at pop‑ups and mobile clinics. Kindbody plans a “fertility bus” offering full on‑site assessments (AMH test, pelvic ultrasound, specialist consultation) and will use the bus to visit NYC and San Francisco, targeting large employers. With the latest funding, Kindbody will open a second Manhattan clinic, its first permanent San Francisco clinic, and is closing an acquisition for a Los Angeles clinic. The company says it will expand services to include mental health, nutrition and gynecological care; it has raised $22 million to date.